Hepoligo
Aabenraa
About Hepoligo
Hepoligo solutions is working to develop a new and better chemical synthesis for the manufacture of the drug Fondaparinux. Fondaparinux is a synthetic heparin product that is used to prevent and treat blood clots.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jun 2016)
- Website: hepoligo.com
- Phone: +45 29 11 71 61
Industries & Categories
Biopharma
Canonical: https://fsome.com/organization/hepoligo-1546322 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.